Loading...
•
Oct 30, 2021
Patterson Q2 2022 Earnings Report
Reported a net sales increase and delivered GAAP earnings per diluted share.
Key Takeaways
Patterson Companies reported a 6.2% increase in net sales to $1.65 billion and GAAP earnings of $0.49 per diluted share for the second quarter of fiscal year 2022. The company has increased its fiscal year 2022 GAAP earnings guidance range to $1.69 to $1.79 per diluted share and adjusted earnings guidance range to $2.00 to $2.10 per diluted share.
Net sales increased 6.2 percent year-over-year to $1.65 billion, and internal sales increased 8.3 percent.
Dental segment internal sales decreased 2.0 percent year-over-year but increased 9.8 percent compared to the pre-pandemic period of the second quarter of fiscal 2020.
Animal Health segment internal sales increased 16.2 percent year-over-year and increased 24.3 percent compared to the pre-pandemic period of the second quarter of fiscal 2020.
Delivered second-quarter GAAP earnings of $0.49 per diluted share and adjusted earnings of $0.58 per diluted share.
Patterson
Patterson
Patterson Revenue by Segment
Revenue by Segment
Dental Revenue
CapyFin.comAnimal Health Revenue
CapyFin.com Forward Guidance
Patterson Companies updated its fiscal 2022 earnings guidance, expecting GAAP earnings to be in the range of $1.69 to $1.79 per diluted share and non-GAAP adjusted earnings to be in the range of $2.00 to $2.10 per diluted share.
Positive Outlook
- GAAP earnings are expected to be in the range of $1.69 to $1.79 per diluted share, compared to prior guidance of $1.64 to $1.74 per diluted share.
- Non-GAAP adjusted earnings are expected to be in the range of $2.00 to $2.10 per diluted share, compared to prior guidance of $1.95 to $2.05 per diluted share.
Revenue & Expenses
Visualization of income flow from segment revenue to net income